IBC has been found to exhibit antiproliferative and proapoptotic activities in HCC by targeting the extracellular signal-regulated kinases (ERKs)/ribosomal S6 kinase 2 (RSK2) signaling pathway [41]. This evidence concerns the gene RPS6KA3 and hepatocellular carcinoma.